The 20th Congress of the Italian Hospital Pulmonologists Association (Aipo) will take place at the Fortezza da Basso from 13th to 16th November 2019. Four non-stop days for an exhaustive update on new therapies and treatments to deal with diseases of the respiratory system, which represent the third cause of death after cardiovascular disease and cancer. Actually, their impact is increasingly growing, also because of factors such as smoke, air pollution and a progressive ageing of the population.
“Italian pulmonology is strong and has to confront itself with the rest of the world. We have to take into consideration progress and the new frontiers introduced by globalisation”, says Venerino Poletti, President of Aipo and of the congress. “This is why the congress will see the participation of international speakers, who will offer the perspective of the other organisations we have to discuss with”.
“Respiratory diseases have a substantial impact on people’s life quality. That is why patients should have access to all treatments which can keep them under control”, commented Albino Sini, member of the Italian Non-Profit Association of COPD Patients, adding: “Our purpose is to inform citizens, patients and family members, encouraging all social and health measures which can improve patients care, as well as adopting all measures aimed at an efficient prevention action. However, it will be a long and difficult process”.